Join Now

Category Archives: BioUtah News

Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform

By Denise Bell | Published December 31, 2020

Co-Diagnostics has announced that it has completed principal design work for a PCR test that would allow researchers to identify certain mutations in a newly detected variant of SARS-CoV-2 known as VUI 202012/01. The new coronavirus strain comprises several mutations and may be more contagious than its predecessors. London and the southeast of Great Britain […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

Vertex Announces FDA Approvals for Expanded Use of Cystic Fibrosis Medicines 

By Denise Bell | Published December 31, 2020

Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF) ages 12 years and older with certain mutations in the CFTR gene. SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) and KALYDECO® (ivacaftor) also received approvals to include additional responsive mutations in people with CF ages 6 years and older and age 4 […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Phoenix PharmaLabs Announces New Investment Offering with Netcapital

By Denise Bell | Published December 31, 2020

Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform. This new offering follows a fund raise in 2019 of more than $1.1 million via Netcapital.  Proceeds from this latest campaign will further support the development […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

State of Utah Announces Updated Plans for Vaccine Distribution

By Kelvyn Cullimore | Published December 28, 2020

Today the State of Utah released updated plans for First Wave of Phase 2 COVID-19 Vaccine Distribution.  Notably the press release states that “Prioritization based on an individual’s employment status in certain industries is no longer being considered by the Unified Command group”.

| Leave a comment

Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test

By Denise Bell | Published December 23, 2020

Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers and is able to meet high demand. The test has recently received FDA emergency use authorization. “We are thrilled to have a point of care rapid antibody test now available. We know hospitals, medical offices, and other […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark

By Denise Bell | Published December 23, 2020

ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The test kit was developed to distinguish SARS-CoV-2 from other respiratory viruses, including influenza A/B and respiratory syncytial virus types A/B that may have similar symptoms. It runs on the firm’s Elite InGenius platform, as well as other […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Presents Data Evaluating Alvocidib in Patients with Acute Myeloid Leukemia and Other Updates on Development Programs at ASH 2020

By Denise Bell | Published December 11, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study evaluating the investigational agent alvocidib, a potent CDK9 inhibitor, in patients with MCL-1 dependent acute myeloid leukemia (AML). These results were presented at the 62nd American Society of Hematology Annual Meeting, which was held virtually December 5-8, […]

| Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in the Dubermatinib Arm of The Leukemia & Lymphoma Society’s Beat AML Master Clinical Trial in Patients with Acute Myeloid Leukemia

By admin | Published December 10, 2020

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in a Phase 1b/2 study evaluating the oral investigational agent, dubermatinib (TP-0903), an AXL kinase inhibitor, in combination with decitabine, in patients 60 years or older with newly diagnosed acute myeloid leukemia (AML) who have TP53 […]

Also posted in Industry News, Life Sciences Industry News | | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 2 of Cancer Study

By admin | Published December 10, 2020

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in the Phase 2 expansion portion of the study evaluating DSP-7888, an investigational immunotherapeutic cancer vaccine that targets Wilms Tumor 1 (WT1), in combination with checkpoint inhibitor pembrolizumab, in patients with platinum-resistant ovarian cancer (PROC). The […]

Also posted in Industry News, Life Sciences Industry News | | Leave a comment

Representative McAdams Honored with the 2020 Champion of Health Care Innovation Award

By Denise Bell | Published December 4, 2020

In a virtual December 3 ceremony, the American Life Sciences Innovation Council (ALSIC), BioUtah and several state and local-based patient organizations, presented Rep. Ben McAdams (UT-4) with the 2020 Champion of Health Care Innovation Award. The award recognizes McAdams for his work in Congress to protect and nurture the important policies that position Utah and […]

Also posted in Policy News | | Leave a comment

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

By Denise Bell | Published December 4, 2020

Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test. Dwight Egan, CEO of Co-Diagnostics, said “tests built on […]

Also posted in Life Sciences Industry News, Press Releases, Utah's Life Sciences Companies | | Leave a comment

Utah COVID-19 Small Business Quarantined Employee Grants

By Denise Bell | Published December 4, 2020

Utah continues to support the business community during the COVID-19 pandemic with its COVID-19 Small Business Quarantined Employee Grant program. If an employee needs to quarantine or isolate due to a COVID-19 exposure or positive test, employers can continue paying them and be reimbursed with this grant program. Utah created this program to reimburse small […]

Also posted in COVID-19 Updates, State News | | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members